From mechanisms of action to therapeutic application: A review on current therapeutic approaches and future directions in systemic sclerosis, Best Pract Res Clin Rheumatol, vol.29, issue.6, pp.756-69, 2015. ,
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres, Annals of the Rheumatic Diseases, vol.70, issue.10, pp.1788-92, 2011. ,
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma, N Engl J Med, vol.378, issue.1, pp.35-47, 2018. ,
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial, JAMA. 25 juin, vol.311, issue.24, pp.2490-2498, 2014. ,
Systemic sclerosis: Autologous HSCT is efficacious, but can we make it safer?, Nat Rev Rheumatol, vol.14, issue.4, pp.189-91, 2018. ,
Mesenchymal stem cells reside in virtually all post-natal organs and tissues, Journal of Cell Science. 9 mai, vol.119, issue.11, pp.2204-2217, 2006. ,
Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?, Front Immunol, vol.9, p.2938, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02304369
Bone marrow-derived mesenchymal stem cell attenuates skin fibrosis development in mice, Int Wound J. déc, vol.11, issue.6, pp.701-711, 2014. ,
Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis, Pharmacol Ther. août, vol.143, issue.2, pp.181-96, 2014. ,
Paracrine Mechanisms of Mesenchymal Stem Cell-Based Therapy: Current Status and Perspectives, Cell Transplant. sept, vol.23, issue.9, pp.1045-59, 2014. ,
The effect of adipose stem cell therapy on pulmonary fibrosis induced by repetitive intratracheal bleomycin in mice, Experimental Lung Research. 16 mars, vol.40, issue.3, pp.117-142, 2014. ,
Effect of intratracheal administration of adipose-derived stromal cells on bleomycin-induced lung injury in a rat model, 33 Mechanisms of Lung Injury and Repair ,
, , p.943, 2015.
Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis, Translational Research. déc, vol.166, issue.6, pp.554-67, 2015. ,
, Antioxidant, and Immunomodulatory Effects of Mesenchymal Stem Cells in HOCl-Induced Systemic Sclerosis: MESENCHYMAL STEM CELLS IN MURINE SSc, vol.68, pp.1013-1038, 2016.
Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis, Cell Transplant, vol.22, issue.5, pp.779-95, 2013. ,
Improvement of Mouth Functional Disability in Systemic Sclerosis Patients over One Year in a Trial of Fat Transplantation versus Adipose-Derived Stromal Cells, Stem Cells Int, p.2416192, 2016. ,
Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial, Ann Rheum Dis. déc, vol.74, issue.12, pp.2175-82, 2015. ,
Long-term follow-up after autologous adipose-derived stromal vascular fraction injection into fingers in systemic sclerosis patients, Curr Res Transl Med. mars, vol.65, issue.1, pp.40-43, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01792172
Adipose stromal vascular fraction and regenerative therapy in SSc: response to the article by Magalon et al, Ann Rheum Dis. 2 févr, 2019. ,
Response to: « Adipose stromal vascular fraction and regenerative therapy in SSc: response to the article by Magalon et al, Ann Rheum Dis. 20 févr, 2019. ,
Could autologous adipose-derived stromal vascular fraction turn out an unwanted source of profibrotic myofibroblasts in systemic sclerosis?, Ann Rheum Dis. 13 mars, 2019. ,
Response to: « Could autologous adipose-derived stromal vascular fraction turn out an unwanted source of profibrotic myofibroblasts in systemic sclerosis? » by Manetti, Ann Rheum Dis. 9 avr, 2019. ,
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling, Sci Rep. 9 mai, vol.9, issue.1, p.7144, 2019. ,
Adipose-derived mesenchymal stromal/stem cells in systemic sclerosis: Alterations in function and beneficial effect on lung fibrosis are regulated by caveolin-1, Journal of Scleroderma and Related Disorders. juin, vol.4, issue.2, pp.127-163, 2019. ,
Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients, Stem Cell Res Ther, vol.8, issue.1, p.236, 2017. ,
Culture and characterization of human bone marrow mesenchymal stem cells, Methods Mol Med, vol.140, pp.67-81, 2007. ,
Pathogen reduction through additivefree short-wave UV light irradiation retains the optimal efficacy of human platelet lysate for the expansion of human bone marrow mesenchymal stem cells, PLoS ONE, vol.12, issue.8, p.181406, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01524322
Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness, FASEB J. févr, vol.15, issue.2, pp.447-57, 2001. ,
Quantitative assessment of angiogenesis and pericyte coverage in human cell-derived vascular sprouts, Inflamm Regen, vol.37, issue.2, 2017. ,
Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells, Blood. 1 mars, vol.111, issue.5, pp.2631-2636, 2008. ,
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, vol.8, issue.4, pp.315-322, 2006. ,
Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis, Ann Rheum Dis. avr, vol.67, issue.4, pp.443-452, 2008. ,
Characteristics of human adipose derived stem cells in scleroderma in comparison to sex and age matched normal controls: implications for regenerative medicine, Stem Cell Res Ther, vol.07, issue.1, p.23, 2017. ,
Phenotypical and Functional Characteristics of In Vitro-Expanded Adipose-Derived Mesenchymal Stromal Cells From Patients With Systematic Sclerosis, Cell Transplant, vol.09, issue.5, pp.841-54, 2017. ,
Senescence in Human Mesenchymal Stem Cells: Functional Changes and Implications in Stem Cell-Based Therapy, IJMS. 19 juill, vol.17, issue.7, p.1164, 2016. ,
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (T reg s ) with a functional phenotype: implications for cellular-based therapy: SSc-MSC preserve immunomodulatory abilities, Clin Exp Immunol. août, vol.173, issue.2, pp.195-206, 2013. ,
Sirtuins and Accelerated Aging in Scleroderma, Curr Rheumatol Rep, vol.20, issue.4, p.16, 2018. ,
Molecular profile and proangiogenic activity of the adipose-derived stromal vascular fraction used as an autologous innovative medicinal product in patients with systemic sclerosis, Ann Rheum Dis. mars, vol.78, issue.3, pp.391-399, 2019. ,
Perivascular Cells in Diffuse Cutaneous Systemic Sclerosis Overexpress Activated ADAM12 and Are Involved in Myofibroblast Transdifferentiation and Development of Fibrosis, J Rheumatol, vol.43, issue.7, pp.1340-1349, 2016. ,
Vascular Remodelling and Mesenchymal Transition in Systemic Sclerosis, Stem Cells Int, p.4636859, 2016. ,
Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis, PLoS ONE, vol.14, issue.7, p.218068, 2019. ,
Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications, J Clin Med. 19 août, vol.8, issue.8, 2019. ,
The introduction of mesenchymal stromal cells induces different immunological responses in the lungs of healthy and M. tuberculosis infected mice. Olszewski MA, éditeur, PLoS ONE. 8 juin, vol.12, issue.6, p.178983, 2017. ,
Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers, Curr Opin Rheumatol, vol.24, pp.165-170, 2012. ,
Geoepidemiology of systemic sclerosis, Autoimmun Rev, vol.9, pp.311-318, 2010. ,
Diagnosis and classification of systemic sclerosis, Clin Rev Allergy Immunol, vol.40, pp.78-83, 2011. ,
The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance, Clin Rev Allergy Immunol, vol.47, pp.334-343, 2014. ,
Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies, Rheumatology (Oxford), vol.51, pp.1017-1026, 2012. ,
Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population, Arthritis Rheum, vol.48, pp.2246-2255, 2003. ,
Mapping and predicting mortality from systemic sclerosis, Ann. Rheum. Dis, vol.76, pp.1897-1905, 2017. ,
The needs of patients with systemic sclerosis--what are the difficulties encountered?, Autoimmun Rev, vol.10, pp.291-294, 2011. ,
Genetic background of systemic sclerosis: autoimmune genes take centre stage, Rheumatology (Oxford), vol.49, pp.203-210, 2010. ,
Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies, Arthritis Rheum, vol.48, pp.1956-1963, 2003. ,
HLA Class I and II Blocks Are Associated to Susceptibility, Clinical Subtypes and Autoantibodies in Mexican Systemic Sclerosis (SSc) Patients, PLoS ONE, vol.10, p.126727, 2015. ,
Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, PLoS ONE, vol.11, p.154255, 2016. ,
Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: a meta-analysis, Int. J. Dermatol, vol.55, pp.408-416, 2016. ,
Epigenetics and systemic sclerosis, Semin Immunopathol, vol.37, pp.453-462, 2015. ,
Environmental risk factors of systemic sclerosis, Semin Immunopathol, vol.37, pp.463-473, 2015. ,
Association of occupational exposure with features of systemic sclerosis, J Am Acad Dermatol, vol.72, pp.456-464, 2015. ,
Systemic sclerosis and exposure to heavy metals: A case control study of 100 patients and 300 controls, Autoimmun Rev, vol.16, pp.223-230, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02109413
Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies, J. Rheumatol, vol.34, pp.97-103, 2007. ,
Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases, N. Engl. J. Med, vol.342, pp.781-790, 2000. ,
Association of Systemic Sclerosis With a Unique Colonic Microbial Consortium. Arthritis & Rheumatology (Hoboken, N.J.), vol.68, pp.1483-1492, 2016. ,
Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease, Arthritis Res. Ther, vol.18, p.278, 2016. ,
Systemic sclerosis: current concepts in pathogenesis and therapeutic aspects of dermatological manifestations, Indian J Dermatol, vol.58, pp.255-268, 2013. ,
Cellular and molecular aspects of vascular dysfunction in systemic sclerosis, Nat Rev Rheumatol, vol.6, pp.453-460, 2010. ,
Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma, J. Clin. Invest, vol.98, pp.785-792, 1996. ,
The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1, Rheumatology (Oxford), vol.48, pp.734-740, 2009. ,
Endothelium-derived nitric oxide: actions and properties, FASEB J, vol.3, pp.31-36, 1989. ,
Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?, J. Rheumatol, vol.21, pp.1838-1844, 1994. ,
, Best Pract Res Clin Rheumatol, vol.22, pp.1093-1108, 2008.
Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis, Arthritis Res. Ther, vol.15, p.55, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00827903
Bone marrow endothelial progenitors are defective in systemic sclerosis, Arthritis Rheum, vol.54, pp.2605-2615, 2006. ,
Increased serum levels of fractalkine and mobilisation of CD34+CD45-endothelial progenitor cells in systemic sclerosis, Arthritis Res. Ther, vol.19, p.60, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01777909
Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis, Arthritis Rheum, vol.43, pp.889-893, 2000. ,
Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation, J. Rheumatol, vol.29, pp.2565-2570, 2002. ,
Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis, N. Engl. J. Med, vol.370, pp.433-443, 2014. ,
Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis, Circ. Res, vol.109, pp.14-26, 2011. ,
Defective vasculogenesis in systemic sclerosis, Lancet, vol.364, pp.603-610, 2004. ,
Low circulating level of CD133+KDR+cells in patients with systemic sclerosis, Clin. Exp. Rheumatol, vol.28, pp.19-25, 2010. ,
Decreased numbers of endothelial progenitor cells in patients in the early stages of systemic sclerosis, Microvasc. Res, vol.98, pp.82-87, 2015. ,
Brief report: impaired in vivo neovascularization capacity of endothelial progenitor cells in patients with systemic sclerosis. Arthritis & Rheumatology (Hoboken, N.J.), vol.66, pp.1300-1305, 2014. ,
Transcriptional regulation of Bim by FOXO3a and Akt mediates scleroderma serum-induced apoptosis in endothelial progenitor cells, Circulation, vol.118, pp.2156-2165, 2008. ,
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis, 2017. ,
Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis, ISRN Rheumatol, p.835948, 2013. ,
TGF-?-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases, Int J Mol Sci, vol.18, 2017. ,
Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1, J. Biol. Chem, vol.270, pp.3423-3428, 1995. ,
Unraveling SSc Pathophysiology, The Myofibroblast. Front Immunol, vol.9, p.2452, 2018. ,
Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts, Arthritis Rheum, vol.48, pp.1964-1978, 2003. ,
,
, Presse Med, vol.35, pp.1903-1915, 2006.
Increased expression of TGF-beta receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype, J. Invest. Dermatol, vol.110, pp.47-51, 1998. ,
Up-regulated expression of transforming growth factor beta receptors in dermal fibroblasts in skin sections from patients with localized scleroderma, Arthritis Rheum, vol.44, pp.731-734, 2001. ,
Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents, Cell Mol Biol, vol.37, pp.823-829, 1991. ,
A role for T helper 2 cells in mediating skin fibrosis in tight-skin mice, Cell Immunol, vol.196, pp.60-68, 1999. ,
Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon, Int J Cardiol, vol.19, pp.335-339, 1988. ,
Platelet-derived serotonin links vascular disease and tissue fibrosis, J Exp Med, vol.208, pp.961-972, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00589662
Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis, Am. J. Pathol, vol.177, pp.187-196, 2010. ,
Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis, Arch. Dermatol. Res, vol.289, pp.567-572, 1997. ,
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts, J Biol Chem, vol.280, pp.36474-36482, 2005. ,
MicroRNA-29, a key regulator of collagen expression in systemic sclerosis, Arthritis Rheum, vol.62, pp.1733-1743, 2010. ,
miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin beta3, Am J Pathol, vol.182, pp.206-216, 2013. ,
The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma, J Immunol, vol.190, pp.3905-3915, 2013. ,
Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes/macrophages, Pathobiology, vol.63, pp.48-56, 1995. ,
Macrophage infiltration in the skin of patients with systemic sclerosis, J Rheumatol, vol.19, pp.1202-1206, 1992. ,
Fibrosis--a lethal component of systemic sclerosis, Nat Rev Rheumatol, vol.10, pp.390-402, 2014. ,
Dermal mast cell degranulation in systemic sclerosis, Arthritis Rheum, vol.33, pp.1702-1709, 1990. ,
Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations, Arthritis Rheum, vol.27, pp.645-653, 1984. ,
Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis, Am J Pathol, vol.151, pp.1751-1758, 1997. ,
Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation, J Clin Immunol, vol.21, pp.210-217, 2001. ,
Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis, J Rheumatol, vol.24, pp.328-332, 1997. ,
Autoantibodies in systemic sclerosis, Autoimmun Rev, vol.12, pp.340-354, 2013. ,
Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes, Arthritis Rheum, vol.54, pp.192-201, 2006. ,
B cells in systemic sclerosis: a possible target for therapy, Autoimmun Rev, vol.10, pp.624-630, 2011. ,
The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab, Rheumatology (Oxford), vol.49, pp.2408-2412, 2010. ,
Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities, Nat Rev Rheumatol, vol.8, pp.42-54, 2011. ,
, Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, Arthritis Rheum, vol.23, pp.581-590, 1980.
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis, J. Rheumatol, vol.15, pp.202-205, 1988. ,
Systemic sclerosis, Lancet, vol.390, pp.1685-1699, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02042780
Criteria for the classification of early systemic sclerosis, J. Rheumatol, vol.28, pp.1573-1576, 2001. ,
classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative, Ann. Rheum. Dis, vol.72, pp.1747-1755, 2013. ,
Anti-topoisomerase I autoantibodies in systemic sclerosis, Autoimmun Rev, vol.8, pp.692-696, 2009. ,
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin, Autoimmun Rev, vol.15, pp.102-109, 2016. ,
Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French cohort and a systematic review and meta-analysis, Arthritis Rheumatol, vol.66, pp.407-417, 2014. ,
Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Arthritis Rheum, vol.57, pp.94-102, 2007. ,
Regenerative Approach to Scleroderma with Fat Grafting, Clin Plast Surg, vol.42, pp.353-364, 2015. ,
Pulmonary complications: one of the most challenging complications of systemic sclerosis, Rheumatology (Oxford), vol.48, pp.40-44, 2009. ,
Interstitial lung disease in systemic sclerosis, Autoimmun Rev, vol.10, pp.248-255, 2011. ,
Scleroderma lung disease, Clin Rev Allergy Immunol, vol.40, pp.104-116, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01573783
The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France, Arthritis Rheum, vol.60, pp.1831-1839, 2009. ,
Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era, Ann Rheum Dis, vol.72, pp.1940-1946, 2013. ,
Cardiovascular involvement in systemic autoimmune diseases, Autoimmun Rev, vol.8, pp.281-286, 2009. ,
Scleroderma renal crisis: a rare but severe complication of systemic sclerosis, Clin Rev Allergy Immunol, vol.40, pp.84-91, 2011. ,
The scleroderma kidney: progress in risk factors, therapy, and prevention, Curr Rheumatol Rep, vol.13, pp.37-43, 2011. ,
Systemic Sclerosis: Gastrointestinal Disease and Its Management, Rheum. Dis. Clin. North Am, vol.41, pp.459-473, 2015. ,
Digestive tract involvement in systemic sclerosis, Autoimmun Rev, vol.11, pp.68-73, 2011. ,
Nutritional status measured by BMI is impaired and correlates with left ventricular mass in patients with systemic sclerosis, Nutrition, vol.30, pp.204-209, 2014. ,
Disease-related malnutrition in systemic sclerosis: evidences and implications, Clin Exp Rheumatol, vol.33, pp.190-194, 2015. ,
Medical Nutrition Therapy for Patients With Advanced Systemic Sclerosis (MNT PASS): A Pilot Intervention Study, JPEN J Parenter Enteral Nutr, vol.41, pp.678-684, 2017. ,
Long-term outcome of patients with systemic sclerosis requiring home parenteral nutrition, Clin Nutr, vol.34, pp.991-996, 2015. ,
Home parenteral nutrition is beneficial in systemic sclerosis patients with gastrointestinal dysfunction, Scand J Rheumatol, vol.45, pp.32-35, 2016. ,
Arthritis in systemic sclerosis: systematic review of the literature and suggestions for the performance of future clinical trials in systemic sclerosis arthritis, Semin Arthritis Rheum, vol.41, pp.801-814, 2012. ,
Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival, Medicine (Baltimore), vol.81, pp.154-167, 2002. ,
Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis, Ann. Rheum. Dis, vol.70, pp.1104-1107, 2011. ,
A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma, Arthritis Rheum, vol.44, pp.1351-1358, 2001. ,
Mycophenolate versus cyclophosphamide for progressive interstitial lung disease associated with systemic sclerosis: a 2-year case control study, Lung, vol.191, pp.483-489, 2013. ,
Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial, Rheumatology (Oxford), vol.57, pp.2106-2113, 2018. ,
,
, Rev Med Interne, 2019.
Efficacy and safety of etanercept in the treatment of scleroderma-associated joint disease, J. Rheumatol, vol.34, pp.1636-1637, 2007. ,
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate), Ann. Rheum. Dis, vol.77, pp.212-220, 2018. ,
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients, J. Clin. Invest, vol.125, pp.2795-2807, 2015. ,
Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial. Arthritis & Rheumatology, vol.70, pp.308-316, 2018. ,
OP0126 A phase 2 study of safety and efficacy of anabasum (JBT-101) in systemic sclerosis, Annals of the Rheumatic Diseases, vol.76, pp.105-105, 2017. ,
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease, N. Engl. J. Med, vol.380, pp.2518-2528, 2019. ,
RISE-SSc: Riociguat in diffuse cutaneous systemic sclerosis, Respir Med, vol.122, issue.1, pp.14-17, 2017. ,
Thérapie cellulaire et cellules souches en, Revue Francophone, pp.34-43, 2018. ,
Embryonic stem cell lines derived from human blastocysts, Science, vol.282, pp.1145-1147, 1998. ,
Characterization and culture of human embryonic stem cells, Nat. Biotechnol, vol.23, pp.699-708, 2005. ,
The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles, J Embryol Exp Morphol, vol.10, pp.622-640, 1962. ,
Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, vol.131, pp.861-872, 2007. ,
Fibroblast precursors in normal and irradiated mouse hematopoietic organs, Exp. Hematol, vol.4, pp.267-274, 1976. ,
,
, Transfus Clin Biol, vol.18, pp.1-12, 2011.
A direct measurement of the radiation sensitivity of normal mouse bone marrow cells, Radiat. Res, vol.14, pp.213-222, 1961. ,
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease, Ann. Rheum. Dis, vol.60, pp.577-584, 2001. ,
Hemopoietic stem cell transplantation in rheumatic diseases--an update, Autoimmun Rev, vol.4, pp.442-449, 2005. ,
Indications et suivi des autogreffes de cellules souches hématopoïétiques dans les maladies auto-immunes et auto-inflammatoires : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC), Bulletin du Cancer, vol.104, pp.169-180, 2017. ,
Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system, Blood, vol.113, pp.214-223, 2009. ,
Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis, Arthritis Rheum, vol.52, pp.1555-1563, 2005. ,
Immune re-education following autologous hematopoietic stem cell transplantation, Autoimmunity, vol.41, pp.577-584, 2008. ,
Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation, Bone Marrow Transplant, vol.47, pp.770-790, 2012. ,
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis, Nat Rev Neurol, vol.13, pp.391-405, 2017. ,
Immune Reconstitution After Hematopoietic Stem Cell Transplantation. Hematopoietic Stem Cell Transplantation for the, Pediatric Hematologist/Oncologist, 2018. ,
Analysis of immune reconstitution after autologous CD34+ stem/progenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4+ T cells, Rheumatology (Oxford), vol.50, pp.944-952, 2011. ,
Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study, Bone Marrow Transplant, vol.49, pp.349-354, 2014. ,
Evolution of serum cytokine profile after hematopoietic stem cell transplantation in systemic sclerosis patients, Bone Marrow Transplant, vol.51, pp.1146-1149, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01704546
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma, N. Engl. J. Med, vol.378, pp.35-47, 2018. ,
Regenerating Immunotolerance in Multiple Sclerosis with, Autologous Hematopoietic Stem Cell Transplant. Front Immunol, vol.9, p.410, 2018. ,
Regulatory T Cells in Systemic Sclerosis: a Comprehensive Review, Clin Rev Allergy Immunol, vol.52, pp.194-201, 2017. ,
Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cells, Blood, vol.127, pp.91-101, 2016. ,
Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+Foxp3+ regulatory T cells, Blood, vol.111, pp.5233-5241, 2008. ,
Haematopoietic stem cell transplantation for autoimmune diseases, Nat Rev Rheumatol, vol.13, pp.244-256, 2017. ,
Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial, Lancet, vol.378, pp.498-506, 2011. ,
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial, JAMA, vol.311, pp.2490-2498, 2014. ,
Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis, Front Immunol, vol.9, p.2390, 2018. ,
Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?, Bone Marrow Transplantation, vol.51, pp.501-505, 2016. ,
A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis, Arthritis Rheum, vol.46, pp.2301-2309, 2002. ,
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, vol.8, pp.315-317, 2006. ,
Paracrine Mechanisms of Mesenchymal Stem Cell-Based Therapy: Current Status and Perspectives, Cell Transplant, vol.23, pp.1045-1059, 2014. ,
Extracellular vesicles derived from mesenchymal stromal cells: a therapeutic option in respiratory diseases?, Stem Cell Res Ther, vol.7, p.53, 2016. ,
Mechanisms of mesenchymal stem/stromal cell function, Stem Cell Res Ther, vol.7, p.125, 2016. ,
Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell, Cell, vol.105, pp.369-377, 2001. ,
On experimental design and discourse in plasticity research, Stem Cell Rev, vol.1, pp.9-13, 2005. ,
Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells, Circulation, vol.109, pp.1292-1298, 2004. ,
Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells, Arterioscler. Thromb. Vasc. Biol, vol.25, pp.2542-2547, 2005. ,
Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives, Circulation, vol.109, pp.656-663, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-00409575
Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells, J. Cell. Physiol, vol.226, pp.2131-2138, 2011. ,
Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B-but not JNK-dependent mechanism, Am. J. Physiol, vol.294, pp.675-682, 2008. ,
Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia, Stem Cell Res Ther, vol.3, p.28, 2012. ,
PD-1/PD-L1 Pathway Mediates the Alleviation of Pulmonary Fibrosis by Human Mesenchymal Stem Cells in Humanized Mice, Am. J. Respir. Cell Mol. Biol, vol.58, pp.684-695, 2018. ,
Adipose tissue-derived stem cell treatment prevents renal disease progression, Cell Transplant, vol.21, pp.1727-1741, 2012. ,
Bone marrow-derived mesenchymal stem cell attenuates skin fibrosis development in mice, Int Wound J, vol.11, pp.701-710, 2014. ,
Mesenchymal stem cells inhibit cutaneous radiation-induced fibrosis by suppressing chronic inflammation, Stem Cells, vol.31, pp.2231-2241, 2013. ,
Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis, J. Autoimmun, vol.70, pp.31-39, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01834289
Adipose tissue-derived stem cells ameliorates dermal fibrosis in a mouse model of scleroderma, Asian Pac J Trop Med, vol.10, pp.52-56, 2017. ,
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells, Lancet, vol.363, pp.1439-1441, 2004. ,
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo, Exp. Hematol, vol.30, pp.42-48, 2002. ,
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli, Blood, vol.99, pp.3838-3843, 2002. ,
Immunomodulatory properties of mesenchymal stromal cells, Blood, vol.110, pp.3499-3506, 2007. ,
Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation, Transplantation, vol.75, pp.389-397, 2003. ,
TNF-? modulates the immunosuppressive effects of MSCs on dendritic cells and T cells, Int. Immunopharmacol, vol.28, pp.1009-1017, 2015. ,
Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells, Stem Cells Dev, vol.24, pp.93-103, 2015. ,
Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation, J. Immunol, vol.164, pp.3596-3599, 2000. ,
Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, vol.105, pp.1815-1822, 2005. ,
Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FASmediated T cell apoptosis, Cell Stem Cell, vol.10, pp.544-555, 2012. ,
Multipotent mesenchymal stromal cells and the innate immune system, Nat. Rev. Immunol, vol.12, pp.383-396, 2012. ,
Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report, Ann. Intern. Med, vol.153, pp.650-654, 2010. ,
Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L, Leukemia, vol.22, pp.1062-1064, 2008. ,
Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases, Arthritis Rheum, vol.63, pp.2540-2542, 2011. ,
Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis, Arthritis Res. Ther, vol.19, p.165, 2017. ,
Combined plasmapheresis and high-dose intravenous immunoglobulin treatment in systemic sclerosis for 12 months: follow-up of immunopathological and clinical effects, Clin. Rheumatol, vol.28, pp.347-350, 2009. ,
,
, Orv Hetil, vol.144, pp.2213-2217, 2003.
Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study, Stem Cell Res Ther, vol.9, p.312, 2018. ,
Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases, Haematologica, vol.95, pp.284-292, 2010. ,
Isolation of putative progenitor endothelial cells for angiogenesis, Science, vol.275, pp.964-967, 1997. ,
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization, Circ Res, vol.85, pp.221-228, 1999. ,
Role of endothelial progenitor cells during ischemiainduced vasculogenesis and collateral formation, Microvasc Res, vol.79, pp.200-206, 2010. ,
Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization, Proc Natl Acad Sci U S A, vol.97, pp.3422-3427, 2000. ,
Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice, J Clin Invest, vol.106, pp.571-578, 2000. ,
Focus on biological identity of endothelial progenitors cells, Eur Rev Med Pharmacol Sci, vol.19, pp.4047-4063, 2015. ,
Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals, Blood, vol.109, pp.1801-1809, 2007. ,
Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells, Blood, vol.105, pp.2783-2786, 2005. ,
Vascular wall progenitor cells in health and disease, Circ. Res, vol.116, pp.1392-1412, 2015. ,
Adipose tissue as an endocrine organ: from theory to practice, J Pediatr (Rio J), vol.83, pp.192-203, 2007. ,
A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives, Microcirculation, vol.4, pp.211-232, 1997. ,
Use of adipose tissue and stromal vascular fraction in hand surgery, Orthop Traumatol Surg Res, vol.103, pp.927-932, 2017. ,
Multilineage cells from human adipose tissue: implications for cell-based therapies, Tissue Eng, vol.7, pp.211-228, 2001. ,
Fat grafting to the hand in patients with Raynaud phenomenon: a novel therapeutic modality, Plast. Reconstr. Surg, vol.133, pp.1109-1118, 2014. ,
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis, Cell Transplant, vol.24, pp.2297-2305, 2015. ,
Regional grafting of autologous adipose tissue is effective in inducing prompt healing of indolent digital ulcers in patients with systemic sclerosis: results of a monocentric randomized controlled study, Arthritis Res. Ther, vol.21, p.7, 2019. ,
Frontal linear scleroderma: long-term result in volumetric restoration of the fronto-orbital area by structural fat grafting, J Craniofac Surg, vol.23, pp.263-265, 2012. ,
Autologous fat transplantation for depressed linear scleroderma-induced facial atrophic scars, Dermatol Surg, vol.34, pp.1659-1665, 2008. ,
Efficacy of Autologous Microfat Graft on Facial Handicap in Systemic Sclerosis Patients, Plast Reconstr Surg Glob Open, vol.4, p.660, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01455651
Autologous fat grafting in the treatment of fibrotic perioral changes in patients with systemic sclerosis, Cell Transplant, vol.24, pp.63-72, 2015. ,
Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients, Stem Cell Res Ther, vol.8, p.236, 2017. ,
Combined PRP and microfat graft for facial disability in systemic sclerosis, J Scleroderma Relat Disord, vol.2, pp.7-11, 2017. ,
Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT), Cytotherapy, vol.15, pp.641-648, 2013. ,
The comparition of biological characteristics and multilineage differentiation of bone marrow and adipose derived Mesenchymal stem cells, Cell Tissue Res, vol.350, pp.277-287, 2012. ,
Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells, Aesthetic Plast Surg, vol.32, pp.56-57, 2008. ,
Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells, Plast Reconstr Surg, vol.119, pp.1423-1424, 2007. ,
Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells, Circ Res, vol.104, pp.1410-1420, 2009. ,
Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation, Stem Cell Res Ther, vol.8, p.145, 2017. ,
Transplantation of freshly isolated adipose tissue-derived regenerative cells enhances angiogenesis in a murine model of hind limb ischemia, Biomed. Res, vol.34, pp.23-29, 2013. ,
Stromal vascular fraction: A regenerative reality? Part 2: Mechanisms of regenerative action, J Plast Reconstr Aesthet Surg, vol.69, pp.180-188, 2016. ,
Comparison between Stromal Vascular Fraction and Adipose Mesenchymal Stem Cells in Remodeling Hypertrophic Scars, PLoS ONE, vol.11, p.156161, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01834377
Comparison of trophic factors secreted from human adipose-derived stromal vascular fraction with those from adipose-derived stromal/stem cells in the same individuals, Cytotherapy, vol.20, pp.589-591, 2018. ,
New fat-derived products for treating skin-induced lesions of scleroderma in nude mice, Stem Cell Res Ther, vol.5, 2014. ,
Safety, tolerability and potential efficacy of injection of autologous adiposederived stromal vascular fraction in the fingers of patients with systemic sclerosis: an openlabel phase I trial, Ann Rheum Dis, vol.74, pp.2175-2182, 2015. ,
Long-term follow-up after autologous adipose-derived stromal vascular fraction injection into fingers in systemic sclerosis patients, Curr Res Transl Med, vol.65, pp.40-43, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01792172
Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis, Cell Transplant, vol.22, pp.779-795, 2013. ,
Improvement of Mouth Functional Disability in Systemic Sclerosis Patients over One Year in a Trial of Fat Transplantation versus Adipose-Derived Stromal Cells, Stem Cells Int, p.2416192, 2016. ,
A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocol, BMJ Open, vol.8, p.20479, 2018. ,
Molecular profile and proangiogenic activity of the adipose-derived stromal vascular fraction used as an autologous innovative medicinal product in patients with systemic sclerosis, Ann. Rheum. Dis, vol.78, pp.391-398, 2019. ,